14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
An acquisition of a new company into your corporate portfolio can be an exciting challenge. As a Hum...
Read More >
On January 3, 2020, Axon Enterprises Inc. filed a complaint against the Federal Trade Commission in ...
Read More >
On June 25, 2019, Governor J. B. Pritzker signed legislation making Illinois the 11th state to appro...
Read More >
As 2020 comes to a much anticipated close and we approach the one-year anniversary of the start of t...
Read More >
Are you familiar with PAGA? Do you have a PAGA claim for unpaid wages filed against you right now? I...
Read More >
One of the first decisions issued by the Alberta Human Rights Tribunal in 2020 offers an important r...
Read More >